col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


63 Results       Page 1

 [1] 
Elsevier: Lung Cancer
  original article Date Title Authors   All Authors
1 [GO] 2022―Feb―10 Incidence and outcomes of central airway obstruction in new lung cancer diagnoses prior to and during COVID-19 Irfan Zaki, Parniya Arooj, Daniel Crowle, Alice Talbot, John Corcoran, Adrian Marchbank, et al. (+2)
2 [GO] 2022―Feb―10 The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit Kimberley Durno, John Conibear
3 [GO] 2022―Feb―10 The impact of virtual lung MDT meetings (MDTMs) in response to the COVID-19 pandemic Hanna Groothuizen, Eunice Aroyewun, Magdalena Zasada, Jenny Harris, Madeleine Hewish, Cath Taylor
4 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic first wave on the volume and type of systemic anticancer therapy (SACT) delivered for thoracic malignancies Marios Decatris, Nowrina Khan, Philip Ryan, Aled Phillips, Sherouk El-Batrawy, Maninder Kalkat, et al. (+5)
5 [GO] 2022―Feb―10 The effects of COVID-19 pandemic on lung cancer diagnosis Mariya Sinthiya, John Howells, Gemma Wright, Syed Mehdi
6 [GO] 2022―Feb―10 The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets Savannah Gysling, Helen Morgan, Onosi Ifesemen, Emma O’Dowd, David Baldwin, Doug West, et al. (+4)
7 [GO] 2022―Feb―10 The continued impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland: results from the second Global Lung Cancer Coalition (GLCC) survey Aoife McNamara, Jackie Fenemore, Jesme Fox, Matthew Peters, Sarah Winstone, Riddhi Thakrar
8 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnoses at North Bristol NHS Trust (NBT) Catherine Coombs, Adriana Pereira, Benjamin Masteman, Abiramy Jeyabalan, Martin Plummeridge, Anna Bibby
9 [GO] 2022―Feb―10 COVID-19 vaccination associated lung mass mimicking a primary lung cancer: a novel manifestation Alexandra Ostler, Georgina Keogh, William Sherwood, Thomas Newsom-Davis
10 [GO] 2022―Feb―10 Contact with lung cancer patients during COVID-19: findings from Ireland and the UK from a global survey of patient experience Aoife McNamara, Jackie Fenemore, Jesme Fox, Mike McKevitt, Riddhi Thakrar
11 [GO] 2022―Feb―10 How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre? Sangary Kathirgamakarthigeyan, Karen Foweraker, Kerstie Johnson, M. Ananth Sivanandan, Abigail Pascoe
12 [GO] 2022―Feb―10 Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset Helen Morgan, Savannah Gysling, Richard Hubbard, John Conibear, Neal Navani, David Baldwin, Emma O’Dowd
13 [GO] 2022―Feb―10 Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients Helene Greenwood, Kamalram Thippu Jayaprakash
14 [GO] 2022―Feb―10 A retrospective comparison of diagnostic pathways for lung cancer before and during the pandemic: a single UK centre experience Hannah Lawrence, Paul Beckett
15 [GO] 2021―Jul―19 An invisible group of COVID-19 victims; Impact on Dutch lung cancer care Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel
16 [GO] 2021―Jul―16 Care Disruptions among Patients with Lung Cancer: A COVID-19 and Cancer Outcomes Study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, Chris Labaki, John A. Steinharter, Douglas A. Tremblay, et al. (+25)
17 [GO] 2021―May―28 Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19 Mary O’Reilly, Mark Doherty
18 [GO] 2021―May―28 Pneumomediastinum, lung cancer and Covid-19 Avinash Aujayeb
19 [GO] 2021―May―28 Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment Lyndsey Phelps, Owen Morris, Nicole Dorey, Victoria Ford, Elizabeth Toy, Robert Biggar, Ian Fraser
20 [GO] 2021―May―28 Covid-19 in lung cancer patients in a DGH Avinash Aujayeb
21 [GO] 2021―May―28 The impact of COVID-19 on lung cancer diagnostics - a multicentre comparison of 2019/2020 data Neal Navani, Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, et al. (+6)
22 [GO] 2021―May―28 Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, Matthew Evison, et al. (+6)
23 [GO] 2021―May―28 Impact of COVID-19 on mesothelioma clinical nurse specialists Bethany Taylor, Angela Tod, Clare Gardiner, Faye Forde, Lorraine Creech, Liz Darlison
24 [GO] 2021―May―28 The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’ Lisa Evetts, Laura Applegate, Amal Singh, Claire Johnson, Sian Wing, Bernadette McBride, et al. (+5)
25 [GO] 2021―May―28 ‘Your cough could be masking something else’ - raising awareness of lung cancer during the Covid-19 pandemic Aoife Mc Namara
26 [GO] 2021―May―28 Adapting lung cancer diagnostics during the Covid-19 pandemic Alex Bull
27 [GO] 2021―May―28 Lung cancer upstaging due to the COVID-19 pandemic Claire Vella, Asif Ashraf, Rajini Sudhir, Daniel Barnes, Jan Brozik, Praveen Rao, et al. (+12)
28 [GO] 2021―May―28 Lung cancer diagnosis: impact of the COVID-19 pandemic Sohail Ali, Rahul Dalal, Sharon Longden, Samuel Roberts, Michael Crawford
29 [GO] 2021―May―28 Anxiety and depression in lung cancer patients during Covid-19 pandemic Anitha Jacob, Rahul Mogal, Andrew Barlow, Rama Vancheeswaran
30 [GO] 2021―May―28 Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic Claire Haslop, Michael Bates, Lavinia Magee, Panagiota Chrysikaki
31 [GO] 2021―May―28 A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic Matt Church, Paul Taylor, Yvonne Summers, Raffaele Califano, Shereen Rafee, Mairead Dixon, et al. (+2)
32 [GO] 2021―May―28 Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience Eman Nasr, Durgesh Rana, Nadira Narine, Haider AL-Najjar
33 [GO] 2021―May―28 Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital Rebecca Sen, Rafiqul Islam Islam, Harriet Baker, Samuel Kim
34 [GO] 2021―May―28 Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust Hazel Watchorn
35 [GO] 2021―May―28 Impact of the Covid-19 pandemic on a District General Hospital EBUS service Matthew Wright, Raquel d’Espiney, Jack Mulholland, Malcolm Lawson
36 [GO] 2021―May―28 The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust Helen McDill, Maged Hassan, Lindsey Taylor, John Corcoran, Cyrus Daneshvar
37 [GO] 2021―May―28 The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland - results from a Global Lung Cancer Coalition (GLCC) survey Lorraine Dallas, Aoife McNamara, Matthew Peters, Riddhi Thakrar
38 [GO] 2021―May―28 The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust Helen McDill, Maged Hassan, Hem Rai, Avik Ghoshal, Emma Graham, Lindsey Taylor, et al. (+2)
39 [GO] 2021―May―28 The impact of the COVID-19 pandemic on referrals and diagnoses of lung cancer in a tertiary hospital Jamie Arberry, Louis Dwyer Hemmings, Jessica Gates, Jennifer Ross, Adrian Draper, Yee-Ean Ong
40 [GO] 2021―May―28 The effects of the COVID-19 pandemic on the lung cancer service at Northwick Park Hospital (NWPH) Lavanya Anandan, Priya Ramachandran, Arnab Datta, Tarangini Sathyamoorthy
41 [GO] 2021―May―28 Impact of the COVID-19 pandemic on the use of systemic anti-cancer therapy for patients diagnosed with malignancy at thoracoscopy in Aneurin Bevan University Health Board Eleanor Barton, Alina Ionescu
42 [GO] 2021―May―28 Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience Sue-Lis Yeo, Syed Muneer-ahmed, Mohammed Haris, Muhammad Ganaie, Nadeem Maddekar, Ahmad AbimusaAsa’ari, et al. (+3)
43 [GO] 2021―May―28 No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients Oskar Lepiarczyk, Jonathan McAleese
44 [GO] 2021―May―28 Lung nodule management in Covid-19: does postponed surveillance matter? Ratnaprashanthika Ratnakumar, Jocelyn Fraser, Rebecca Nicholls, Jennifer Quint, Susannah Bloch
45 [GO] 2021―May―28 Emergency presentation of lung cancer: did it increase during the COVID-19? Cai Lupei, Muhammad Tariq, Imran Hussain, Nadeem Maddekar, Shahul Leyakathali khan
46 [GO] 2021―May―28 Impact of the coronavirus pandemic and national lockdown on a lung cancer service - opportunities for innovation Puneet Malhotra, Amy McIntosh, Pauline Murphy, Victoria Peers
47 [GO] 2021―May―28 The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training Nathan Riddell, Artemio Gonzales, Alina Ionescu
48 [GO] 2021―May―28 Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic? Romy Ni Chleirigh, Joshua Macarthur, Sarah MacRae
49 [GO] 2021―May―28 Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung) Kathryn Banfill Banfill, Gareth Price, Kate Wicks, Shahreen Ahmad, Hannah Bainbridge, Mike Bayne, et al. (+24)
50 [GO] 2021―May―28 Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed? James Hargrave, Claire Hastings, Jackie Fenemore, Lorraine Dallas, Tom Newsom-Davis, Robert Rintoul
51 [GO] 2021―May―14 Lung Cancer Patients with COVID-19 in Spain: GRAVID study Mariano Provencio, José María Mazarico Gallego, Antonio Calles, Mónica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, et al. (+22)
52 [GO] 2021―May―08 Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center Clémence Basse, Catherine Daniel, Alain Livartowski, Sophie Beaucaire-Danel, Nicolas Girard
53 [GO] 2021―May―05 Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis Haike Lei, Yue Yang, Wei Zhou, Mengyang Zhang, Yang Shen, Dan Tao, et al. (+4)
54 [GO] 2021―Apr―30 Safety monitoring of 2 and 4-weekly adjuvant durvalumab for patients with Stage III NSCLC; implications for the COVID-19 pandemic and beyond Kroopa Joshi, Abdul Muhith, Mariam Obeid, Charlotte Milner-Watts, Nadia Yousaf, Sanjay Popat, et al. (+4)
55 [GO] 2020―Dec―24 Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
56 [GO] 2020―Dec―16 Cancer treatment in the coronavirus disease pandemic Jia-Tao Zhang, Wen-Zhao Zhong, Yi-Long Wu
57 [GO] 2020―Jun―17 Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic Hsu-Liang Chang, Po-Ju Wei, Kuan-Li Wu, Hung-Ling Huang, Chih-Jen Yang
58 [GO] 2020―Jun―12 The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2 Kai Wang, Yang Liu, Tian Hu, Yumei Liu, Chao Liu
59 [GO] 2020―May―30 Covid-19 and lung cancer: A greater fatality rate? Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero, Berta Obispo, Almudena Martín Marino, Mar Pérez-Pérez, et al. (+3)
60 [GO] 2020―May―26 Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak Zhongxing Liao, Eleonor Rivin del Campo, Ahmed Salem, Qingsong Pang, Hui Liu, Jose Luis Lopez Guerra
61 [GO] 2020―May―11 Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire? Vincenzo Di Noia, Alessandro D’Aveni, Michela Squadroni, Giordano Berett, Giovanni Luca Ceresoli
62 [GO] 2020―May―06 Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience David Rossi
63 [GO] 2020―May―04 A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? María Sereno, Gerardo Gutiérrez-Gutiérrez, Carmen Sandoval, Sandra Falagan, Ana María Jimenez-Gordo, María Merino, et al. (+4)
 [1] 

63 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec